Stockscreener 앱 받기
40.46
3.61%
1.41
시장 영업 전:
40.75
0.29
+0.72%
전일 마감가:
$39.05
열려 있는:
$40
하루 거래량:
840.35K
Relative Volume:
1.19
시가총액:
$2.31B
수익:
$681.88M
순이익/손실:
$122.63M
주가수익비율:
19.18
EPS:
2.11
순현금흐름:
$220.18M
1주 성능:
+11.09%
1개월 성능:
+18.03%
6개월 성능:
+26.28%
1년 성능:
+27.80%
1일 변동 폭
$39.65
$40.93
1주일 범위
$35.72
$40.93
52주 변동 폭
$28.14
$41.61
하모니 바이오 Stock (HRMY) Company Profile
명칭
Harmony Biosciences Holdings Inc
전화
(484) 539-9800
주소
630 W GERMANTOWN PIKE, PLYMOUTH MEETING
HRMY을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
HRMY
Harmony Biosciences Holdings Inc
|
40.46 | 2.31B | 681.88M | 122.63M | 220.18M | 2.11 |
|
VRTX
Vertex Pharmaceuticals Inc
|
427.89 | 110.19B | 10.63B | -479.80M | -1.35B | -1.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
687.80 | 75.58B | 13.85B | 4.65B | 3.32B | 40.41 |
|
ARGX
Argen X Se Adr
|
647.39 | 38.71B | 1.86B | -40.29M | -1.28B | -0.85 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
264.99 | 34.18B | 2.09B | -332.26M | 16.06M | -2.62 |
|
BNTX
Biontech Se Adr
|
117.25 | 28.11B | 3.30B | -501.07M | 1.03B | -2.1146 |
하모니 바이오 Stock (HRMY) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2024-12-17 | 개시 | H.C. Wainwright | Buy |
| 2024-10-10 | 재개 | Raymond James | Outperform |
| 2024-09-10 | 개시 | UBS | Buy |
| 2024-06-21 | 개시 | Citigroup | Buy |
| 2024-01-02 | 다운그레이드 | BofA Securities | Neutral → Underperform |
| 2023-09-25 | 다운그레이드 | Goldman | Neutral → Sell |
| 2023-09-07 | 개시 | Berenberg | Buy |
| 2023-04-20 | 개시 | BofA Securities | Neutral |
| 2022-10-14 | 업그레이드 | Janney | Neutral → Buy |
| 2022-10-14 | 업그레이드 | Jefferies | Hold → Buy |
| 2022-08-03 | 다운그레이드 | Jefferies | Buy → Hold |
| 2022-07-13 | 다운그레이드 | Goldman | Buy → Neutral |
| 2022-07-07 | 개시 | Mizuho | Buy |
| 2022-04-14 | 개시 | Cantor Fitzgerald | Overweight |
| 2021-12-01 | 개시 | Oppenheimer | Outperform |
| 2021-11-04 | 개시 | Raymond James | Outperform |
| 2021-09-23 | 개시 | Needham | Buy |
| 2021-03-29 | 업그레이드 | Goldman | Neutral → Buy |
| 2020-09-14 | 개시 | Goldman | Neutral |
| 2020-09-14 | 개시 | Jefferies | Buy |
| 2020-09-14 | 개시 | Piper Sandler | Overweight |
모두보기
하모니 바이오 주식(HRMY)의 최신 뉴스
Research Analysts Offer Predictions for HRMY FY2025 Earnings - MarketBeat
Harmony Biosciences chief commercial officer sells shares worth $1.15m By Investing.com - Investing.com Canada
ARS Investment Partners LLC Invests $841,000 in Harmony Biosciences Holdings, Inc. (NASDAQ:HRMY) - MarketBeat
Should Value Investors Buy Harmony Biosciences (HRMY) Stock? - Yahoo Finance
Harmony Biosciences stock reaffirms buy rating ahead of Q4 results - MSN
What is HC Wainwright's Forecast for HRMY FY2029 Earnings? - MarketBeat
Harmony Biosciences Holdings, Inc. (NASDAQ:HRMY) Insider Jeffrey Dierks Sells 10,507 Shares - MarketBeat
HC Wainwright Reiterates "Buy" Rating for Harmony Biosciences (NASDAQ:HRMY) - MarketBeat
Harmony Biosciences stock reaffirms buy rating ahead of Q4 results By Investing.com - Investing.com Australia
H.C. Wainwright Reiterates Buy Rating on Harmony Biosciences Holdings Inc. (HRMY) - StreetInsider.com
Hennion & Walsh Asset Management Inc. Raises Stock Holdings in Harmony Biosciences Holdings, Inc. (NASDAQ:HRMY) - MarketBeat
Harmony Biosciences officer sells shares worth $388,840 By Investing.com - Investing.com Canada
Harmony Biosciences officer sells shares worth $388,840 - Investing.com
A Glimpse Into The Expert Outlook On Harmony Biosciences Through 7 Analysts - Benzinga
Harmony Biosciences chief commercial officer sells shares worth $265,946 By Investing.com - Investing.com South Africa
(HRMY) Trading Advice - Stock Traders Daily
Harmony Biosciences chief commercial officer sells shares worth $265,946 - Investing.com
How Much Upside is Left in Harmony Biosciences (HRMY)? Wall Street Analysts Think 39.48% - MSN
Why Harmony Biosciences (HRMY) Might be Well Poised for a Surge - MSN
Harmony Biosciences price target raised to $32 from $31 at BofA - Yahoo Finance
HRMY or RGEN: Which Is the Better Value Stock Right Now? - Yahoo Finance
JPMorgan Chase & Co. Purchases 93,622 Shares of Harmony Biosciences Holdings, Inc. (NASDAQ:HRMY) - MarketBeat
Harmony stock remains Outperform at Oppenheimer, guidance supports optimism By Investing.com - Investing.com Australia
Why Harmony Biosciences (HRMY) Is the Top Small Cap Stock to Buy with the Highest Upside Potential - Yahoo Finance
Harmony Biosciences (NASDAQ:HRMY) Shares Gap UpHere's What Happened - MarketBeat
Harmony Biosciences' (HRMY) "Buy" Rating Reaffirmed at Needham & Company LLC - MarketBeat
Harmony Biosciences Holdings Inc. (HRMY) PT Raised to $61 at Oppenheimer - StreetInsider.com
Harmony Biosciences reports strong revenue growth for WAKIX By Investing.com - Investing.com South Africa
Harmony Biosciences reports strong revenue growth for WAKIX - Investing.com India
Harmony Biosciences Projects Strong Revenue Growth for 2025 - TipRanks
Harmony Biosciences (HRMY) Reports Strong 2024 Revenues, Provides 2025 Revenue Guidance and Highlights Key Pipeline Catalysts - StreetInsider.com
Harmony Biosciences Revenue Surges 23% to $714M, Sets Ambitious $820M Target for 2025 - StockTitan
Top 10 Small Cap Stocks to Buy with the Highest Upside Potential - Insider Monkey
Top 5 US Stocks To Buy In January 2025 - Investing.com
HARMONY BIOSCIENCES TO PARTICIPATE IN PIPER SANDLER 35th ANNUAL HEALTHCARE CONFERENCE - GuruFocus.com
Principal Financial Group Inc. Cuts Stock Position in Harmony Biosciences Holdings, Inc. (NASDAQ:HRMY) - MarketBeat
Brokerages Set Harmony Biosciences Holdings, Inc. (NASDAQ:HRMY) Target Price at $49.80 - MarketBeat
HARMONY BIOSCIENCES TO PARTICIPATE IN OPPENHEIMER MOVERS IN RARE DISEASE SUMMIT - Kilgore News Herald
How the (HRMY) price action is used to our Advantage - Stock Traders Daily
Harmony Biosciences to Present at 43rd Annual J.P. Morgan Healthcare Conference - MSN
Harmony Biosciences (NASDAQ:HRMY) Trading Down 2.3%What's Next? - MarketBeat
Declining Stock and Solid Fundamentals: Is The Market Wrong About Harmony Biosciences Holdings, Inc. (NASDAQ:HRMY)? - Simply Wall St
Research Analysts Offer Predictions for HRMY FY2024 Earnings - MarketBeat
State Street Corp Has $49.62 Million Stock Position in Harmony Biosciences Holdings, Inc. (NASDAQ:HRMY) - MarketBeat
Comprehensive Market Analysis of Latest Published 9 Rare Genetic Disorders Reports | DelveInsight - GlobeNewswire Inc.
HARMONY BIOSCIENCES TO PRESENT AT THE 43RD ANNUAL J.P. MORGAN HEALTHCARE CONFERENCE - BioSpace
HC Wainwright & Co. Initiates Coverage of Harmony Biosciences Holdings (HRMY) with Buy Recommendation - MSN
Harmony Biosciences (NASDAQ:HRMY) Shares Up 3.6%Here's Why - MarketBeat
Harmony Biosciences Holdings, Inc. (NASDAQ:HRMY) Sees Large Decrease in Short Interest - MarketBeat
Harmony Biosciences (NASDAQ:HRMY) Earns Buy Rating from Analysts at HC Wainwright - MarketBeat
하모니 바이오 (HRMY) 재무 분석
매출
순이익
현금흐름
주당 순 이익
4.81%
자본화:
|
볼륨(24시간):